-
December 9, 2021 Non-Hallucinogenic DMT? Psilera Bioscience Reports Progress on ‘Well-Tolerated’ DerivativeFurther in vivo studies with PSIL-002 will evaluate its antidepressant, anxiolytic, and anti-addictive properties, specifically...
-
December 2, 2021 DEA Boosts Psychedelics Production (Again) to Meet Research DemandDrug Enforcement Agency also addresses concerns from Native American Church regarding peyote poaching for mescaline...
-
November 15, 2021 DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production QuotasDrug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide...
-
October 22, 2021 Psychedelic Business Spotlight: October 22This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field...
-
October 8, 2021 How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate...
-
October 5, 2021 Seattle Decriminalizes Natural PsychedelicsSeattle City Council unanimously approves a resolution declaring entheogen-related activities should be among lowest law...
-
September 29, 2021 World’s Richest Person Elon Musk: ‘People Should Be Open to Psychedelics’The Tesla and SpaceX founder, estimated to be worth nearly $200 billion, has previously hinted...
-
September 24, 2021 How Cybin Is ‘Revolutionizing’ Mental Healthcare with Novel Psychedelic CompoundsCEO Doug Drysdale explains several key factors in making psychedelic-assisted therapy accessible for the millions...
-
September 24, 2021 Psychedelic Business Spotlight: September 24, 2021This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic...
-
September 16, 2021 How Mind Medicine Australia Is Tackling Deadly Mental Health Crisis with PsychedelicsCharity co-founder Tania de Jong says Covid-19 pandemic has led to "a huge spike in...
